Achievements by CSGMT/JEMS · MMS: The Collaborative Study Group for the Micronucleus Test in the Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan

Mutation Research - Reviews in Genetic Toxicology

Volumn 340, Issue 2-3, 1996, Pages 151-174

  Sutou, Shizuyo ^a  

^a Itoham Central Research Institute   (Japan)

Author keywords

Collaborative Study Group for the Micronucleus Test (CSGMT); Environmental Mutagen Society of Japan (JEMS); Mammalian Mutagenesis Study Group (MMS); Micronucleus test

Indexed keywords

2 NITROPROPANE; 4 NITROQUINOLINE 1 OXIDE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; BENZENE; BENZO[A]PYRENE; CHLORMETHINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYTARABINE; DIMETHYLNITROSAMINE; ETHYLNITROSOUREA; FLUOROURACIL; MERCAPTOPURINE; MITOMYCIN C; N (2 FLUORENYL)ACETAMIDE; NICKEL; PHENACETIN; PHENOBARBITAL; POTASSIUM BROMATE; POTASSIUM CHROMATE; PROCARBAZINE; PROPIOLACTONE; TESTOSTERONE; THYMINE; TOLONIUM CHLORIDE; TRETAMINE; UNINDEXED DRUG; URETHAN; VINBLASTINE; VINCRISTINE;

ARTICLE; CARCINOGENICITY; CLINICAL PROTOCOL; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING;

MAMMALIA;

EID: 0029313913     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0165-1110(96)90046-9     Document Type: Article

References (131)

1. Aeschbacher H.U. Rates of micronuclei induction in different mouse strains. Mutation Res. 164:1986;109-115.
2. Aeschbacher H.U., Gottowick D., Meier H., Poot A.W. Mutagen-sensitive strain of mice. Mutation Res. 59:1979;301-304.
3. Aiso K., Kanisawa M., Okamoto T., Aikawa N. Systematic studies on the toxicity of nitrofuran derivatives. II. Microscopic examination of rats fed 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide and nitrofurazone for one year (in Japanese, English summary). J. Food Hyg. Soc. Japan. 5:1964;120-129.
4. Asanami S., Shimono K., Uejima M., Yamamura E., Hirono H., Takeuchi M. Mouse micronucleus test of β-butyrolactone and β-propiolactone. MMS Commun. 2:1994;109-116.
5. Asanami H., Shimono K., Kurisu K. A significant increase of micronucleated erythrocytes was observed in mice made moribund by fasting. MMS. Commun. 2:1995.
6. Asano N., Hagiwara T. The mouse peripheral blood micronucleus test with 2- acetylaminofluorene using the acridine orange supravital staining method. Mutation Res. 278:1992;153-157.
7. Asano N., Morita T., Watanabe Y. Micronucleus test with colchicine given by intraperitoneal injection and oral gavage. Mutation Res. 223:1989;391-394.
8. Awogi T., Sato T. Micronucleus test with benzo[a]pyrene using a single peroral administration and intraperitoneal injection in males of the MS/Ae and CD-1 mouse strains. Mutation Res. 223:1989;353-356.
9. Awogi T., Murata K., Uejima M., Kuwahara T., Asanami S., Shimono K., Morita T. Induction of micronucleated reticulocytes by potassium bromate and potassium chromate in CD-1 male mice. Mutation Res. 278:1992;181-185.
10. Carriott M.L., Pier C.E., Kokkino A.J. A simplified protocol for the mouse bone marrow micronucleus assay. J. Appl. Toxicol. 8:1988;141-144.
11. Sex difference in the micronucleus test. Mutation Res. 172:1986;151-163.
12. Strain difference in the micronucleus test. Mutation Res. 204:1988;307-316.
13. CSGMT (1989) CITED A GREAT MANY TIMES IN TABLE 2. PLEASE COMPLETE.
14. Single versus multiple dosing in the micronucleus test: the summary of the fourth collaborative study by CSGMT/JEMS·MMS. Mutation Res. 234:1990;205-222.
15. Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: The summary report of the 5th collaborative study by CSGMT/JEMS·MMS. Mutation Res. 278:1992;83-89.
16. Protocol recommended by the CSGMT/JEMS·MMS for the short-term mouse peripheral blood micronucleus test. Mutagenesis. 10:1995;153-159.
17. Cui X., Higashikuni N., Sutou S. Comparative study of micronucleus induction by nitrogen mustard in the peripheral blood and bone marrow of mice and rats. MMS Commun. 3:1995;69-75.
18. Davis A., Barale R., Brum G., Foster R., Gunter T., Hautefeuille H., van der Heijden C.A., Knaap A.G.A.C., Krowke R., Kuroki T., Loprieno N., Malaveille C., Merker H.J., Monaco M., Mosesso P., Neubert D., Norpa N., Sorsa M., Vogel E., Voogd C.E., Umeda M., Bartsch H. Evaluation of the genetic and embryotoxic effects of bis(tri-n-butyltin)oxide (TBTO), a broad spectrum pesticide, in multiple in vivo and in vitro short-term tests. Mutation Res. 188:1987;65-95.
19. Devaki N.S., Rao M.S. A study on the mutagenicity of phenobarbitone using the micronucleus test in Swiss mice. IRCS Med. Sci. 9:1981;937-938.
20. EEC. Methods for the determination of Toxicity. EEC Directive 79/831. Official Journal of the European Communities No. L259/10. 1979.
21. EEC. Official Journal of the European Community No. L251 19/9/1984. 1984;. B. Method for determination of toxicity. B12. Other effects, Mutagenicity, Micronucleus test.
22. EPA. Health effects test guidelines (TSCA). EPA Report, EPA 560/6-82-001. 1982.
23. FRG (Federal Republic of Germany). Protocols for toxicity trals: micronucleus test. 1979.
24. Hachiya N., Aruga F., Aida M., Quan T.-H., Takizawa Y. Micronucleus induction in mouse bone marrow by phenacetin administered intraperitoneally or orally. Mutation Res. 223:1989;365-368.
25. Hara M., Nakagawa S., Fujioka E., Ayukawa E., Izushi T. Detection of micronuclei in peripheral blood of mitomycin C-treated mice using supravital staining with acridine orange. Mutation Res. 278:1992;175-179.
26. 1 male mice. Environ. Mutagen Res. Commun. 16:1994;211-215.
27. Hata, Makita T.T., Horiya N., Ozawa S., Ohba M., Naito J., Shibuya T. Micronucleus test with 6-mercaptopurine monohydrate administered intraperitoneally and orally. Mutation Res. 223:1989;349-352.
28. Hatakeyama Y., Nakajima E., Atai H., Suzuki S. Effect of benzene in a micronucleus test on peripheral blood using acridine orange-coated slides. Mutation Res. 278:1992;193-195.
29. Hatanaka Y., Kitagawa Y., Toyoda Y., Kawata T., Ando N., Kawabata Y., Iwai M., Arimura H. Micronucleus test with cyclophosphamide using mouse peripheral blood reticulocytes. Mutation Res. 278:1992;99-101.
30. Hayashi M., Sofuni T., Ishidate M. Jr. High-sensitivity in micronucleus induction of a mouse strain (MS). Mutation Res. 105:1982;253-256.
31. Hayashi M., Sofuni T., Ishidate M. Jr. An application of acridine orange fluorescent staining to the micronucleus test. Mutation Res. 120:1983;241-247.
32. Hayashi M., Yoshimura I., Sofuni T., Ishidate M. Jr. A procedure for data analysis of the rodent micronucleus test involving historical control. Environ. Mol. Mutagen. 13:1989a;347-356.
33. Hayashi M., Sutou S., Shimada H., Sato S., Sasaki Y.F., Wakata A. Difference between intraperitoneal and oral gavage application in the micronucleus test, The 3rd collaborative study by CSGMT/JEMS·MMS. Mutation Res. 223:1989b;329-344.
34. Hayashi M., Morita T., Kodama Y., Sofuni T., Ishidate M. Jr. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutation Res. 245:1990;245-249.
35. Hayashi M., Kodama Y., Awogi T., Suzuki T., Asita A.O., Sofuni T. The micronucleus assay using peripheral blood reticulocytes from mitomycin C- and cyclophosphamide treated rats. Mutation Res. 278:1992;209-213.
36. Hayashi M., Tice R.R., MacGregor J.T., Anderson D., Blakey D.H., Kirsh-Volders M., Oleson F.B. Jr., Pacchierotti F., Romagna F., Shimada H., Sutou S., Vannier B. In vivo rodent erythrocyte micronucleus assay. Mutation Res. 312:1994;293-304.
37. Heddle J.A., Hite M., Kirkhart B., Mavournin M., MacGregor J.T., Newell G.W., Salamone M. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Res. 123:1983;61-118.
38. Higashikuni N, Sutou S. Bis(tri-n-butyltin)oxide induces micronuclei in both males and females. MMS Commun. No. 7:1993;27-29.
39. Higashikuni N., Sutou S. An optimal, generalized sampling time of 30 and 6 hr after double dosing in the mouse peripheral blood micronucleus test. Mutagenesis. 10:1995;313-319.
40. Higashikuni N., Baba T., Nakamura T., Sutou S. The micronucleus test with peripheral reticulocytes from phenacetin-treated mice. Mutation Res. 278:1992;159-164.
41. Higashikuni N., Hara M., Nakagawa S., Sutou S. 2-(2-Furyl)-3-(5-nitro-2- furyl)acrylamide (AF-2) is a weak in vitro clastogen as revealed by the micronucleus assay. Mutation Res. 320:1994a;149-156.
42. Higashikuni N., Morita T., Sutou S. N-Nitrosodiethylamine induces micronuclei at doses below the maximum tolerated dose. MMS Commun. 2:1994b;1-6.
43. Hitotsumachi S., Kimura Y., Katoh M., Ishihara N., Hara T., Shibuya T. Micronucleus tests on N-ethyl-N-nitrosourea with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutation Res. 278:1992;113-115.
44. Holmstrom M. Induction of micronuclei in bone marrow of mice exposed to 1, 2, or 3 daily doses of urethane. Mutation. Res. 234:1990;147-154.
45. Honda S., Hayashi M., Shinagawa Y., Sato S., Naruse Y., Kagamimori S. Methylthiouracil does not induce micronuclei in mouse reticulocytes. MMS Commun. 2:1994;37-40.
46. ICPEMC. Screening strategy for chemicals that are potential germ-cell mutagenesis in mammals. ICPEMC committee 1 final report. Mutation Res. 114:1983;117-118.
47. Inoue T., Imanishi H., Watanabe M., Sasaki Y.F., Shirasu Y., Ando N., Ishii S. Micronucleus test with procarbazine hydrochloride administered by intraperitoneal injection and oral gavage. Mutation Res. 223:1989;411-414.
48. Itagaki Y., Sato S., Furuhashi T., Sutou S., Tutikawa K. Strain difference in the mouse spot test: Results from the cross between two H-2 congenic strains and the PW strain. Exp. Oncol. (Life Sci. Adv.). 7:1988;65-68.
49. Iwakura K., Tamura H., Matsumoto A., Ajimi S., Ogura S., Kakimoto K., Matsumoto T., Hayashi M. The micronucleus assay with peripheral blood reticulocytes by acridine orange supravital staining with 1-β-D-arabinofuranosyl-cytosine. Mutation Res. 278:1992;131-137.
50. JEMS·MMS. The atlas of chromosomal aberrations induced by chemicals. 1988;Asakura- Shoten, Tokyo. 1988.
51. JMHW (The Ministry of Health and Welfare, Japan). Guidelines for toxicity studies required for applications for approval to manufacture (import) drugs (Part I). Notification No. 118. 1984;the Pharmaceuticals Bureau, Ministry of Health and Welfare, Japan.
52. JMHW (The Ministry of Health and Welfare, Japan). Guidelines for testing of drugs for toxicity. Pharmaceutical Affairs Bureau Notice. (No. 24):1989.
53. Kasahara Y., Wakata A., Nakai Y., Yuno Y., Miura D., Yagi K., Hirabayashi K., Makita T. The micronucleus test using peripheral blood reticulocytes from methotrexate-treated mice. Mutation Res. 278:1992;145-151.
54. Kimura Y., Hitotsumachi S. No induction of micronuclei by vinyl bromide in mouse bone marrow cells. MMS Commun. 2:1994;9-11.
55. Kishi M., Horiguchi Y., Watanabe S., Hayashi M. Validation of the mouse peripheral blood micronucleus assay using acridine orange supravital staining with urethane. Mutation Res. 278:1992;205-208.
56. Kondo K., Ozawa S. Micronucleus test with ethyl methanesulfonate in mouse peripheral blood reticulocytes stained supravitally using acridine orange-coated slides. Mutation Res. 278:1992;109-111.
57. Kondo, Suzuki K.H., Hoshi K., Yasui H. Micronucleus test with ethyl methanesulfonate administered by intraperitoneal injection and oral gavage. Mutation Res. 223:1989;373-375.
58. Kondo Y., Honda S., Nakajima M., Miyahana K., Hayashi M., Shinagawa Y., Sato S., Inoue K., Nito S., Ariyuki F. Micronucleus test with vincristine sulfate and colchicine in peripheral blood reticulocytes of mice using acridine orange supravital staining. Mutation Res. 278:1992;187-191.
59. Kondo Y., Nakajima E., Nito S., Asano Y., Ariyuki F., Higashiguchi T. Assessment of the human carcinogens arsenic acid and arsenic trichloride in the mouse micronucleus assay. MMS Commun. 2:1994;117-121.
60. Kondoh S., Sugihara T. No induction of micronuclei in mice after intraperitoneal injection of 2,4-diaminoanisole dihydrochloride. MMS Commun. 2:1994a;95-96.
61. Kondoh S., Sugihara T. Melphalan is a potent in vivo clastogen as revealed by the mouse bone marrow micronucleus test. MMS Commun. 2:1994b;97-98.
62. Kuramochi M., Seki H., Tazawa T., Sakai S., Sakai Y. the micronucleus test with mouse peripheral blood on N-ethyl-N-nitro-N-nitrosoguanidine and mitomycin C. Mutation Res. 278:1992;121-125.
63. Lorke D. A new approach to practical acute toxicity testing. Arch. Toxicol. 54:1983;275-287.
64. MacGregor J.T., Wehr C.M., Gould D.H. Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test. Environ. Mutagen. 2:1980;509-515.
65. MacGregor J.T., Heddle J.A., Hite M., Margolin B.M., Ramel C., Salamone M.F., Tice R.R., Wild D. Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. Mutation Res. 189:1987;103-112.
66. MacGregor J.T., Wehr C.M., Henika P.R., Shelby M.D. The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studies. Fund. Apple. Toxicol. 14:1990;513-522.
67. Mavournin K.H., Blakey D.H., Cimino M.C., Salamone M.F., Heddle J.A. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Res. 239:1990;29-80.
68. McCann J., Spingarn N.E., Kobori J., Ames B.N. Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc. Natl. Acad. Sci. USA. 72:1975;979-983.
69. Mirkova E., Ashby J. Activity of the human carcinogens benzidine and 2-naphthylamine in male mouse bone marrow micronucleus assays. Mutagenesis. 3:1988;437-439.
70. Miura D., Kasahara Y., Morita K., Nakai Y., Hirabayashi K., Wada H., Takahashi Y., Izawa Y., Makita T. Acetamide induced neither bacterial gene mutations nor micronuclei in mice. MMS Commun. 2:1994;49-57.
71. Miyaji T. Acute and chronic toxicity of furylfuramide in rats and mice. Tohoku J. Exptl. Med. 103:1971;331-369.
72. Miyamae Y., Hirai O. No induction of micronuclei in the peripheral reticulocytes of N-nitrosopiperidine-treated mice. MMS Commun. 2:1994;45-47.
73. Miyamae Y., Hirai O., Yamada H., Sakaguchi M., Sasaki Y.F., Kojima H., Sato A., Higashikuni N., Sutou S. The induction of micronuclei in mice by dimethylsulfate and diethylsulfate. MMS Commun. 3:1995;25-32.
74. Mizuhashi F., Miura K., Kitagaki T., Nishitomi T., Hashimoto A., Kido A. Administration-route-related deference in the micronucleus test with 7,12-dimethylbenz[a]anthracene . Mutation Res. 223:1989;357-360.
75. Morita T. No clastogenicity of 1,4-dioxane as examined in the mouse peripheral blood micronucleus test. MMS Commun. 2:1994;7-8.
76. Morita T., Asano N., Awogi T., Sasaki Y.F., Sato S.-I., Shimada H., Sutou S., Suzuki T., Wakata A., Sofuni T., Hayashi M. Evaluation of the rodent micronucleus assay to screen IARC carcinogens (Group 1, 2A and 2B), The summary report of the 6th collaborative study by CSGMT/JEMS·MMS. Mutation Res. 1996;. in press.
77. Nakai Y., Hirabayashi K., Takahashi Y., Miura D., Kasahara Y., Morita K., Izawa Y. The genetic toxicology of o-toluidine with special reference to its non- clastogenicity in vivo. MMS Commun. 2:1994;99-108.
78. Nakajima M., Kitazawa M., Oba K., Kitagawa Y., Toyoda Y. Effect of route of administration in the micronucleus test with potassium bromate. Mutation Res. 223:1989;399-402.
79. Noguchi T., Asakura M., Sugiyama T., Matsushima T. Asbestos (chrysotile) does not induce micronuclei in mouse bone marrow by intraperitoneal or intravenous injections. MMS Commun. 2:1994a;75-77.
80. Noguchi T., Asakura M., Sugiyama T., Matsushima T. N-Nitroso-di-n-propylamine induces micronuclei in partially hepatectomized rat liver but not in mouse bone marrow cells. MMS Commun. 2:1994b;79-82.
81. Ochiai T., Furuya T., Sekita K., Uchida O., Naito K., Kawamata K., Horiuchi S., Tobe M., Ikeda Y. Induction of forestomach tumors in mice fed furylfuramide, 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2). Bullet. Natl. Inst. Hyg. Sci. (No. 100):1982;80-84.
82. OECD. Genetic Toxicology: Micronucleus test. OECD guidelines for testing of chemicals. 1983.
83. Ohuchida A., Furukawa A., Kondo Y., Ono T., Nito S. Micronucleus test with vincristine administered by intraperitoneal injection and oral gavage. Mutation Res. 223:1989;395-398.
84. Ohuchida A., Furukawa A., Yoshida J., Watanabe M., Aruga F., Miwa Y., Shinkawa K., Kinae N. Micronucleus assay on 5-fluorouracil and 6-mercaptopurine with mouse peripheral blood reticulocytes. Mutation Res. 278:1992;139-143.
85. Ohuchida A., Kouchi Y., Sugiyama C., Kobayashi H., Atai H., Hatakeyama Y. The in vivo mutagenic potential of hydrazine and its derivatives. MMS Commun. 3:1995;15-23.
86. Ozawa S. No clastogenicity of dichloromethane in the mouse bone marrow as administered intraperitoneally. MMS Commun. 2:1994;29-31.
87. Ozawa S., Kimura Y., Hitotsumachi S. Acetaldehyde induces micronuclei in mice administered intraperitoneally. MMS Commun. 2:1994;33-35. [95.].
88. Richold M., Chandley A., Ashby J., Gatehouse D.G., Bootman J., Henderson L. In vivo cytogenetic assays. Kirkland D.J. Basic Mutagenicity Test: UKEMS recommended procedures. 1990;115-141 Cambridge University Press.
89. Romagna F., Matsumura H., Watanabe M., Kano T., Shirasu Y., Ohmori K., Yamada H., Sasaki Y.F. Micronucleus evaluation in peripheral blood reticulocytes of mice treated with procarbazine hydrochloride or mitomycin C. Mutation Res. 278:1992;197-204.
90. Salamone M.F., Heddle J.A. The bone marrow micronucleus assay: Rational for a revised protocol. Serres de. Chemical Mutagens. Vol. 8:1983;111-149 Plenum Press, New York and London.
91. Salamone M.F., Mavournin K.H. Bone marrow micronucleus assay: A review of the mouse stocks used and their published mean spontaneous micronucleus frequencies. Environ. Mol. Mutagen. 23:1994;239-273.
92. Sasaki Y.F., Sakaguchi M., Yamada H. Evidence for non-clastogenicity to mice of possible human carcinogen (IARC) p-cresidine . MMS Commun. 2:1994a;83-85.
93. Sasaki Y.F., Sakaguchi M., Yamada H., Matsuhashi T. Evaluation of micronucleus induction in mice by four organochlorine pesticides: 1,2-dibromo-3-chloropropane, 1,3-dichloropropene, 1,2-dichloroethane, and nitrofen. MMS Commun. 2:1994b;87-93.
94. Satake K., Hayakawa Y., Watanabe M. N-Nitrosodiethanolamine is not a clastogen as revealed by the mouse bone marrow micronucleus test. MMS Commun. 2:1994;13-14.
95. Sato S., Taketomi M. The mouse micronucleus test with formaldehyde. MMS Commun. 2:1994a;69-73.
96. Sato S., Taketomi M. Cytogenetic effects of 2-nitropropane in vitro and in vivo. MMS Commun. 2:1994b;123-127.
97. Sato S., Kitajima H., Konoshi S., Takizawa H., Inui N. Mouse strain difference in the induction of micronuclei by polycyclic aromatic hydrocarbons. Mutation Res. 192:1987;185-189.
98. Sato S., Inui N., Ikeda Y., Hiraga Y. A comparison of intraperitoneal injection and oral gavage in the micronucleus test with mitomycin C in mice. Mutation Res. 223:1989;387-390.
99. Sato S., Taketomi M., Morita T. Simplified mouse peripheral reticulocytes micronucleus test with dimethylnitrosamine. Mutation Res. 278:1992;103-107.
100. Sato S., Taketomi M., Nakajima M., Kitazawa M., Shimada H., Ito S., Igarashi M., Higashikuni N., Sutou S., Sasaki Y.F., Hayashi M., Sofuni T., Higashiguchi T., Nito S., Kondo Y., Honda S., Hayashi M., Shinagawa Y., Nakajima E., Oka Y., Shimoi K., Hokabe Y., Morita A., Kinae N., Takeuti M., Hirono H., Yamamura E., Tamai K. Effect of aging on spontaneous micronucleus frequencies in peripheral blood of nine mouse strains: the results of the 7th collaborative study organized by CSGMT/JEMS·MMS. Mutation Res. 338:1995;51-57.
101. Schlegel R., MacGregor J.T. The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fisher 344 rats: Implications for cytogenetic screening. Mutation Res. 9:1984;522-549.
102. Schmid W. The micronucleus test. Mutation Res. 74:1975;347-356.
103. Shimada Y., Ozawa S. 4-Chloro-o-phenylenediamine is clastogenic in the mouse bone marrow micronucleus test. MMS Commun. 2:1994;25-28.
104. Shimada H., Sutou S., Hayashi M., Tanaka N., Shibuya T., Nishi Y. The micronucleus test: Examination of guidelines and proposal of a standard protocol. Toxicol. Forum. 7:1984a;564-568. Part 1 (in Japanese).
105. Shimada H., Sutou S., Hayashi M., Tanaka N., Shibuya T., Nishi Y. The micronucleus test: Examination of guidelines and proposal of a standard protocol. Toxicol. Forum. 7:1984a;648-654. Part 1 (in Japanese).
106. Shimada H., Sutou S., Hayashi M., Tanaka N., Shibuya T., Nishi Y. The micronucleus test: Examination of guidelines and proposal of a standard protocol. Toxicol. Forum. 7:1984b;648-654. Part 2 (in Japanese).
107. Shimada H., Suzuki H., Itoh S., Hattori C., Matsuura Y., Tada S., Watanabe C. The micronucleus test of benzene with mouse and rat peripheral blood reticulocytes. Mutation Res. 278:1992;165-168.
108. Shimada Y., Ono S., Kobayashi S., Cui X., Sutou S. No micronucleus induction by phenobarbital-sodium as revealed in mouse bone marrow and peripheral blood tests. MMS Commun. 3:1995;61-67.
109. Shindo Y., Toyoda Y., Kawamura K., Kurebe M., Shimada H., Hattori C., Satake S. Micronucleus test with potassium chromate (VI) administered intraperitoneally and orally to mice. Mutation Res. 223:1989;403-406.
110. Sugiyama C., Kobayashi H., Kishi M. Micronucleus test with 2-acetylaminofluorene by intraperitoneal injection and oral administration. Mutation Res. 223:1989;361-364.
111. Sugiyama C., Miyamae Y., Kobayashi H., Fujino Y., Mori M., Ohara K. The micronucleus test of methyl methanesulfonate with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutation Res. 278:1992;117-120.
112. Sugiyama C., Kobayashi H., Asano N., Ohuchida A., Kimura Y., Hitotsumachi S. In vivo and in vitro cytogenetic studies of four sex hormones. MMS Commun. 3:1995;1-13.
113. Sutou S., Sato S. Maternal effect on micronucleus induction in MS/Ae mice. Environ Mol. Mutagen. 15:1990;125-130.
114. Sutou S., Shimada H., Wakata A., Awogi T., Ohuchida A., Hayashi M., Sofuni T. Scrutiny of protocols for the micronucleus test with mice: Achievements by CSGMT/JEMS·MMS. Environ. Mol. Mutagen. 14:1989a;S15.
115. Sutou S., Shimada H., Wakata A., Awogi T., Ohuchida A., Hayashi M., Sofuni T. Scrutiny of protocols for the micronucleus test with mice: Achievements by CSGMT/JEMS·MMS. Environ. Mol. Mutagen. 14:1989a;194.
116. Sutou S., Sato S., Hitotsumachi S., Kimura Y. Administration-route-related difference in the micronucleus test with N-ethyl-N-nitrosourea . Mutation Res. 223:1989b;377-381.
117. Suzuki S., Atai H., Hatakeyama Y., Hata M., Nakagawa S. Administration route-related differences in the micronucleus test with benzene. Mutation Res. 223:1989;407-410.
118. Suzuki T., Tamai K., Kodama Y., Asita A.O., Matsuoka A., Sofuni T., Kurita M., Ohtsuki H., Hiwatashi T., Hayashi M. Micronucleus induction in mouse peripheral reticulocytes by 7,12-dimethylbenz[a]anthracene . Mutation Res. 278:1992;169-173.
119. Suzuki H., Watanabe C., Nakae S. 1,2,3,4,5,6-Hexachlorocyclohexane does not induce micronucleus in mice. MMS Commun. 2:1994;41-43.
120. Tice R.R., Erexson G., Hillard C.J., Huston J.L., Boehm R.M., Gulati D., Shelby M.D. Effect of treatment protocol and sample time on the frequencies of micronucleated polychromatic erythrocytes in mouse bone marrow and peripheral blood. Mutagenesis. 5:1990a;313-321.
121. Tice R., Erexson G., Hillard C.J., Shelby M.D. The induction of micronucleated polychromatic erythrocytes in mice using single and multiple treatments. Mutation Res. 234:1990b;187-193.
122. Tonomura A., Sasaki M.S. Chromosomal aberrations and DNA repair synthesis in cultured human cells exposed to nitrofurans. Japan. J. Genet. 48:1973;291-294.
123. Tsuyoshi T., Takeuchi M., Hirano H., Masamoto Y. Micronucleus test with methyl methanesulfonate administered by intraperitoneal injection and oral gavage. Mutation Res. 223:1989;383-386.
124. UKEMS. Basic test battery; Minimal criteria; Professional standards; Interpretation; Selection of supplementary assays. Report of the UKEMS sub-committee on guidelines for mutagenicity testing. 1983.
125. Wakata A., Yamashita T., Tamaoki M., Ohshima T., Kojima M. Micronucleus test with cyclophosphamide administered by intraperitoneal injection and oral gavage. Mutation Res. 223:1989;369-372.
126. Williams C.V., Tinwell H., Ashby J. Activity of the moue germ cell mutagen diethyl sulfate in the mouse bone marrow micronucleus assay. MMS. Commun. 2:1995.
127. Yahagi T., Nagao M., Hara K., Matsushima T., Sugimura T., Bryan G.T. Relationship between the carcinogenic and mutagenic or DNA-modifying effects of nitrofuran derivatives, including 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide, a food additive. Cancer Res. 34:1974;2266-2273.
128. Yamamoto K., Kikuchi Y. Studies on micronuclei time response and on the effects of multiple treatments of mutagens on induction of micronuclei. Mutation Res. 90:1981;163-173.
129. Yamamura E., Hirono H., Takeuchi M., Kojima M., Aoki S. The micronucleus test with mouse peripheral blood reticulocytes using acridine orange-coated slides with triethylenemelamine. Mutation Res. 278:1992;127-130.
130. 3) did not induce micronuclei in mouse bone marrow cells. MMS Commun. 2:1994a;17-19.
131. Yamamura E., Hirono H., Takeuchi M. 1,3-Propane sultone-induced micronuclei in mouse peripheral blood. MMS Commun. 2:1994b;21-23.